Drug
Ciprofloxacin
Ciprofloxacin: highest development phase Approved, developed by Bayer, Emergent BioSolutions, Sandoz and others. 4 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Bayer, Emergent BioSolutions, Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| CIPROFLOXACIN HYDROCHLORIDE | Approved | |
| Ciprofloxacin (Cipro, BAYQ3939) NCT00930982 | Phase 2 | Bronchiectasis |
| Ciprofloxacin 500Mg Tablet NCT04067011 | Phase 2 | Anthrax |
| Ciprofloxacin Extended-Release Tablets 1000 mg NCT00649662 | Phase 1 | Healthy |
Latest
No recent events.
Follow Ciprofloxacin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.